Open Access

Rivaroxaban in cardiovascular protection - Getting to the heart of the matter

Event: ESC Congress 2018
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 26 August 2018
Time: 13:00 - 14:00

Session

4 presentations in this session

A holistic approach to cardiovascular protection with rivaroxaban.

Speaker: Professor A. Kakkar (London, GB)
Thumbnail

Managing the clinical challenges of the multimorbid patient with atiral fibrillation.

Speaker: Doctor J. Cox (Halifax, CA)
Speaker: Doctor C. Gibson (Boston, US)
Thumbnail

Managing the clinical challenges of the patient with atherothrombotic disease.

Speaker: Professor M. Cowie (London, GB)
Speaker: Professor R. Welsh (Edmonton, CA)
Thumbnail

Closing remarks - Rivaroxaban in cardiovascular protection - Getting to the heart of the matter.

Speaker: Professor J. Camm (London, GB)
Thumbnail

6 speakers from this session

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Doctor Jafna Cox

Dalhousie University, Halifax (Canada)
6 presentations
0 follower

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
10 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)
15 presentations
0 follower

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
55 presentations
0 follower

This platform is supported by

logo Novo Nordisk